1. Home
  2. MEIP vs PC Comparison

MEIP vs PC Comparison

Compare MEIP & PC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MEIP
  • PC
  • Stock Information
  • Founded
  • MEIP 2000
  • PC 2012
  • Country
  • MEIP United States
  • PC Singapore
  • Employees
  • MEIP N/A
  • PC N/A
  • Industry
  • MEIP Biotechnology: Pharmaceutical Preparations
  • PC Restaurants
  • Sector
  • MEIP Health Care
  • PC Consumer Discretionary
  • Exchange
  • MEIP Nasdaq
  • PC Nasdaq
  • Market Cap
  • MEIP 13.3M
  • PC 11.7M
  • IPO Year
  • MEIP 2003
  • PC 2024
  • Fundamental
  • Price
  • MEIP $2.53
  • PC $0.67
  • Analyst Decision
  • MEIP Hold
  • PC
  • Analyst Count
  • MEIP 1
  • PC 0
  • Target Price
  • MEIP N/A
  • PC N/A
  • AVG Volume (30 Days)
  • MEIP 21.5K
  • PC 354.5K
  • Earning Date
  • MEIP 05-13-2025
  • PC 02-15-2025
  • Dividend Yield
  • MEIP N/A
  • PC N/A
  • EPS Growth
  • MEIP N/A
  • PC N/A
  • EPS
  • MEIP N/A
  • PC N/A
  • Revenue
  • MEIP N/A
  • PC $3,345,964.00
  • Revenue This Year
  • MEIP N/A
  • PC N/A
  • Revenue Next Year
  • MEIP N/A
  • PC N/A
  • P/E Ratio
  • MEIP N/A
  • PC N/A
  • Revenue Growth
  • MEIP 33.76
  • PC N/A
  • 52 Week Low
  • MEIP $1.46
  • PC $0.60
  • 52 Week High
  • MEIP $4.10
  • PC $5.73
  • Technical
  • Relative Strength Index (RSI)
  • MEIP 78.43
  • PC N/A
  • Support Level
  • MEIP $2.21
  • PC N/A
  • Resistance Level
  • MEIP $2.95
  • PC N/A
  • Average True Range (ATR)
  • MEIP 0.15
  • PC 0.00
  • MACD
  • MEIP 0.05
  • PC 0.00
  • Stochastic Oscillator
  • MEIP 81.48
  • PC 0.00

About MEIP MEI Pharma Inc.

MEI Pharma Inc is focused on the clinical development of novel therapies for cancer. The company's clinical drug candidate includes Pracinostat, an orally available histone deacetylase inhibitor for the treatment of patients with acute myeloid leukemia and myelodysplastic syndrome. Its clinical development portfolio also includes Zandelisib, an oral inhibitor of phosphatidylinositide 3-kinase delta for the treatment of patients with recurrent chronic lymphocytic leukemia or follicular non-Hodgkin's lymphoma; and ME-344, an isoflavone-based mitochondrial inhibitor for the treatment of HER2-negative breast cancer and Pracinostat, an oral histone deacetylase inhibitor. Geographically, all the business activities function through the region of the United States.

About PC Premium Catering (Holdings) Limited Ordinary Shares

Premium Catering (Holdings) Ltd is a company that conducts its operations through its subsidiary is mainly engaged in food catering for functions, events, and workers in Singapore. Are specialized in Indian, Bangladesh, and Chinese cuisine and all its food products are Halal food which is permissible for consumption by Muslims to consume. Are an ACRA registered company and licensed by SFA to operate and process food business. Serve highquality value-packed food, company deliver's a reliable and dependable service to meet customer's daily meal requirements. The Company recognizes revenue from sales of budgeted prepared meals.

Share on Social Networks: